|
New paradigms for the treatment of aspergillosis:
azoles (click for details) |
|
|
|
Air fungal load in three high-risk departments of a
tertiary hospita (click for details) |
|
|
|
Infectious outcomes after alternative donor stem cell
transplantation: a retrospective cohort comparison (click for details) |
|
|
|
New paradigms for the treatment of aspergillosis:
echinocandins
(click for details) |
|
|
|
Endogenous Aspergillus endophthahnitis:
Report of three cases and review of the literature (click for details) |
|
|
|
Invasive aspergillosis with predominant thyroid and
myocardial involvement (click for details) |
|
|
|
Hyper-IgE and recurrent infection syndrome (Job’s
syndrome): a rare disease with common problems
(click for details) |
|
|
|
In vitro evaluation of voriconazole in combination
with antifungals (click for details) |
|
|
|
In vitro susceptibility of clinical isolates of
Aspergillusfimigatus to conventional and lipid
formulations of amphotericin B in 2-drug
combination with caspofimgin and micafungin
(click for details) |
|
|
|
Opportunistic infections of the respiratory system in
adults patients with HIV/AIDS
(click for details) |
|
|
